Isotopia Molecular Imaging

Isotopia Molecular Imaging was established in 2007 by renowned Israeli scientists and experts in the field of radio pharmaceuticals, and in collaboration with the International Metronotario investment organization. Advancing cancer diagnosis and therapy is among the most critical and worthy goals for humanity. At ISOTOPIA, this goal is our mission. We persistently strive to provide proven and advanced targeted therapies to accelerate cancer care Prostate cancer is one of the leading causes of morbidity and mortality in men in the western world, and the second most common cancer in men worldwide. Through our multidisciplinary group of radiopharmaceutical experts and multiple production facilities, our clients are seamlessly provided with customized theranostics solutions that meet and exceed their needs.